🏃 FOX is up +6% after Q2 earnings. Are mid-cap stocks making their move?Unlock Mid-Caps

Super Micro Computer, Airbnb, Rivian and Lyft fall premarket; Shopify rises

Published 2024-08-07, 07:48 a/m
© Reuters
DIS
-
AMGN
-
CVS
-
SMCI
-
NVO
-
SHOP
-
LYFT
-
RIVN
-

Investing.com -- U.S. stock futures rose Wednesday, continuing to rebound after the tech-led rout at the start of the week.

Here are some of the biggest premarket U.S. stock movers today

  • Walt Disney (NYSE:DIS) stock fell 0.1% in volatile trading after the entertainment giant reported a drop in profits at its Experiences segment that includes parks and consumer products, which makes up just over half of profit, even as its Entertainment unit, with the combined streaming businesses of Disney+, Hulu and ESPN+, posted a profit for the first time.

  • Super Micro Computer (NASDAQ:SMCI) stock fell 14% after the information technology company announced disappointing fiscal fourth-quarter earnings, as well as a 10-for-1 stock split, set to begin trading on a split-adjusted basis at the start of October.

  • Airbnb (NASDAQ:ABNB) stock slumped 15% after the house rental company forecast third-quarter revenue below estimates and warned of shorter booking windows, suggesting travelers were waiting until the last minute to book due to economic uncertainty.

  • CVS Health (NYSE:CVS) stock fell 0.8% after the healthcare conglomerate cut its 2024 profit forecast, hit by increased medical costs at its health insurance unit as demand for healthcare services remained elevated.

  • Lyft (NASDAQ:LYFT) stock fell 14% after the ride-hailing company offered up a soft forecast for the current quarter ending September, taking the sheen off strong second-quarter results.

  • Novo Nordisk (CSE:NOVOb) (NYSE:NVO) stock fell 5.1% after the drug maker trimmed its full-year profit outlook after reporting weaker-than-expected quarterly sales of its popular weight-loss drug Wegovy, stirring worries among investors about stiffening competition.

  • Shopify (TSX:SHOP) (NYSE:SHOP) stock soared 17% after the e-commerce platform beat expectations for quarterly revenue, as its artificial intelligence-powered tools helped pull in more merchants to its e-commerce services.

  • Amgen (NASDAQ:AMGN) stock fell 2% after the drugmaker said second-quarter profit slipped 1% as higher expenses offset a 20% increase in revenue.

  • Rivian (NASDAQ:RIVN) stock dropped 8.7% after the EV manufacturer forecast that production would not rise this year and said deliveries in the third quarter would be slightly lower.

  • Evotec (NASDAQ:EVO) ADRs dropped 22% after the German drug company issued a profit warning, citing ongoing challenges within its Shared R&D segment and accelerated investments in biologics capacity expansion.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.